XML 48 R36.htm IDEA: XBRL DOCUMENT v3.22.4
EMPLOYEE BENEFIT AND DEFERRED COMPENSATION PLANS (Tables)
12 Months Ended
Dec. 31, 2022
Compensation plans:  
Schedule of stock appreciation rights activity

Units

    

Range of

    

Vested

    

Nonvested

    

Total

    

 Grant Values

Outstanding at December 31, 2019

 

6,207

 

6,069

 

12,276

$

0.92–$3.73

Granted

 

21

 

681

 

702

$

4.70

Exercised

 

(877)

 

 

(877)

$

1.31–$2.50

Forfeited

 

 

(63)

 

(63)

$

2.50

Vested

 

1,410

 

(1,410)

 

 

  

Converted

 

(6,761)

 

(5,277)

 

(12,038)

$

0.92–$4.70

Outstanding at December 31, 2020

 

 

 

Schedule of valuation assumptions

Fair market value of common stock

$

19.00

Volatility

 

 

36.7

%

Expected term (years)

 

 

6.5

Expected dividend yield

 

 

%

Risk-free interest rate

 

 

0.4

%

Schedule of ESPP valuation assumptions

Offering Period Ending

5/31/2023

11/30/2022

5/31/2022

11/30/2021

5/31/2021

Fair market value of common stock

$

17.21

$

11.16

$

17.38

$

19.89

$

25.83

Volatility

 

46.4

%

 

35.4

%

 

37.3

%

 

35.1

%

35.1

%

Expected term (years)

 

0.5

 

0.5

 

0.5

 

0.5

0.5

Expected dividend yield

 

-

%

 

-

%

 

-

%

 

-

%

-

%

Risk-free interest rate

 

4.7

%

 

1.6

%

 

0.1

%

 

0.1

%

0.1

%

Schedule of stock-based compensation cost related to incentive awards

For the year ended December 31, 

2022

    

2021

    

2020

Stock-based compensation expense:

Stock options

$

7,081

$

17,533

$

143,123

RSUs

 

9,286

 

2,964

 

171

RSAs

 

2,768

 

5,126

 

4,284

ESPP

594

537

326

Total stock-based compensation expense

$

19,729

$

26,160

$

147,904

Schedule of stock based compensation cost in consolidated statement of operations

For the year ended December 31, 

2022

    

2021

    

2020

Stock-based compensation expense:

Cost of revenues, software subscriptions

$

2,090

$

2,336

 

$

14,663

Cost of revenues, services

 

1,433

 

2,648

 

 

21,472

Research and development

 

1,798

 

2,620

 

 

14,694

Selling and marketing

 

6,284

 

6,371

 

 

29,551

General and administrative

 

8,124

 

12,185

67,524

Total stock-based compensation expense

$

19,729

$

26,160

$

147,904

Amended Options  
Compensation plans:  
Schedule of Option activity

Weighted

Weighted

Average

Average

Remaining

Aggregate

Exercise

Contractual

Intrinsic

Amended Option Activity

Units

Price

Life (Years)

Value

Outstanding at December 31, 2019

3,849

$

0.19

*

$

17,344

Exercised through June 30

(173)

$

0.30

$

759

Amendment and exchange of options

(3,676)

$

0.19

*

$

69,177

Outstanding at December 31, 2020

*Options have indefinite contractual lives

Stock options  
Compensation plans:  
Schedule of Option activity

Weighted

Weighted

Average

Average

Remaining

Aggregate

Exercise

Contractual

Intrinsic

2020 Plan Option Activity

Units

Price

Life (Years)

Value

Outstanding at January 1, 2020

Issued in connection with Converted SARs

12,038

$

2.76

Issued in connection with Amended Options

3,676

$

0.19

*

Total options granted

15,714

$

2.16

Forfeited

(156)

$

3.29

Exercised

(3,682)

$

1.21

Outstanding at December 31, 2020

11,876

$

2.44

5.3

$

384,883

Granted

779

$

23.06

Forfeited

(292)

$

4.06

Exercised

(2,863)

$

2.04

Outstanding at December 31, 2021

9,500

$

4.20

5.2

$

110,843

Forfeited

(100)

$

5.31

Expired

(1)

$

32.16

Exercised

(891)

$

2.70

2020 Plan options outstanding at December 31, 2022

8,508

$

4.34

4.3

$

86,514

2020 Plan options exercisable at December 31, 2022

6,125

$

2.95

3.4

$

70,785

*Amended Options have indefinite contractual lives

Schedule of outstanding, vested and exercisable

Options Outstanding

Options Vested and Exercisable

    

    

Weighted

    

    

Weighted

Average

Average

Exercise Prices

Units

Life (Years)

Units

Life (Years)

$0.15 to $0.71

 

1,698

1,698

$2.15

 

326

2.1

326

2.1

$2.50

 

2,156

3.5

2,156

3.5

$2.67

 

409

4.2

409

4.2

$3.17

 

988

5.3

237

5.4

$3.73

1,514

6.8

737

6.8

$4.70

658

7.1

316

7.1

$18.47

213

8.9

53

8.9

$18.96

235

8.6

105

8.6

$19.00

 

66

8.7

17

8.7

$32.16

 

245

8.2

71

7.4

 

8,508

 

6,125

Schedule of valuation assumptions

Option Valuation Period

Q4 2021

    

 

Q3 2021

    

Q3 2021

    

 

Q2 2021

    

 

Q1 2021

    

Fair market value of common stock

$

18.47

 

$

18.96

$

19.00

 

$

17.66

 

$

32.16

Volatility

 

 

37.4

%

 

 

37.1

%

 

37.1

%

 

 

36.8

%

 

 

36.8

%

Expected term (years)

 

 

5.0

 

5.0

 

5.0

 

6.0

 

6.0

Expected dividend yield

 

 

%

 

%

 

%

 

%

 

%

Risk-free interest rate

 

 

1.3

%

 

0.8

%

 

0.9

%

 

0.4

%

 

0.4

%

Restricted Stock Units  
Compensation plans:  
Schedule of restricted activity

    

    

    

Weighted

Average

Grant Date Fair

Units

Value Per Share

Outstanding at January 1, 2020

 

Granted

 

101

$

23.80

Outstanding at December 31, 2020

101

23.80

Granted

478

27.07

Vested

 

(15)

29.67

Forfeited

 

(34)

25.18

Outstanding at December 31, 2021

530

$

26.49

Granted

2,240

13.55

Vested

(68)

21.96

Forfeited

(140)

15.59

Outstanding at December 31, 2022

2,562

$

15.90

Restricted Stock Awards  
Compensation plans:  
Schedule of restricted activity

    

Weighted

Average

Grant Date Fair

Units

Value Per Share

Outstanding at January 1, 2020

 

Granted

 

694

$

19.00

Vested

 

(21)

 

19.00

Forfeited

 

(3)

 

19.00

Outstanding at December 31, 2020

670

19.00

Granted

59

17.66

Vested

(363)

19.00

Forfeited

(40)

19.00

Outstanding at December 31, 2021

326

$

18.76

Granted

106

9.92

Vested

(188)

18.58

Forfeited

(9)

19.00

Outstanding at December 31, 2022

235

$

14.91